I need assistance completing the balance sheet with the percentages of net sales on the balance sheet assumptions provided below, for example with "other current assets" for $1,029 I subtracted, added, multiplied and divided 7% and no result was the correct option.

\begin{tabular}{|c|c|} \hline \begin{tabular}{c} Medtronic PLC \\ Consolidated Balance Sheet \end{tabular} & \begin{tabular}{l} April \\ 26, \\ 2019 \end{tabular} \\ \hline \multicolumn{2}{|l|}{ Current assets } \\ \hline Cash and cash equivalents & $4,393 \\ \hline Investments & 5,455 \\ \hline Accounts receivable, net & 6,222 \\ \hline Inventories, net & 3,753 \\ \hline Other current assets & 1,029 \\ \hline Total current assets & 20,852 \\ \hline Property, plant, and equipment, net & 4,675 \\ \hline Goodwill & 39,959 \\ \hline Other intangible assets, net & 20,560 \\ \hline Tax assets & 729 \\ \hline Other assets & 1,014 \\ \hline Total assets & $87,789 \\ \hline \multicolumn{2}{|l|}{ Current liabilities } \\ \hline Current debt obligations & $838 \\ \hline Accounts payable & 1,953 \\ \hline \end{tabular} \begin{tabular}{|l|r|} \hline Accounts payable & 1,953 \\ \hline Accrued compensation & 2,189 \\ \hline Accrued income taxes & 567 \\ \hline Other accrued expenses & 2,925 \\ \hline Total current liabilities & 8,472 \\ \hline Long-term debt & 24,486 \\ \hline Accrued compensation and retirement benefits & 1,651 \\ \hline Accrued income taxes & 2,838 \\ \hline Deferred tax liabilities & 1,278 \\ \hline Other liabilities & 363 \\ \hline Total liabilities & 39,088 \\ \hline Shareholders' equity & \\ \hline Ordinary shares & 0 \\ \hline Additional paid-in capital & 25,021 \\ \hline Retained earnings & 26,270 \\ \hline Accumulated other comprehensive loss & (2,711) \\ \hline Total shareholders' equity & 48,580 \\ \hline Noncontrolling interests & 121 \\ \hline Total equity & 48,701 \\ \hline Total liabilities and equity & $87,789 \\ \hline \end{tabular} \begin{tabular}{|c|c|c|} \hline Investments & & No change \\ \hline Accounts receivable, less allowance & 20.496 & of net sales \\ \hline Inventories, net & 12.3% & of net sales \\ \hline Other current assets & 7% & of net sales \\ \hline Goodwill & & No change \\ \hline Tax assets & 5% & of net sales \\ \hline Other assets & 3.3% & of net sales \\ \hline Accounts payable & 6.49 & of net sales \\ \hline Accrued compensation (current liability) & 7.2% & of net sales \\ \hline Accrued compensation and retirement benefits (noncurrent liability) & & No change \\ \hline Accrued income taxes (current liability) & 1.9% & of net sales \\ \hline Other accrued expenses & 9.6% & of net sales \\ \hline Accrued income taxes (noncurrent liability) & 9.3% & of net sales \\ \hline Deferred tax liabilities & 4.2% & of net sales \\ \hline Other liabilities & 2.5% & of net sales \\ \hline Ordinary shares & & No change \\ \hline Accumulated other comprehensive loss & & No change \\ \hline Net income attributable to noncontrolling interest & $19 & million \\ \hline Dividends in FY2020 & $2,853 & million \\ \hline \end{tabular} \begin{tabular}{|c|c|c|} \hline Goodwill & & No change \\ \hline Tax assets & 5% & of net sales \\ \hline Other assets & 3.39 & of net sales \\ \hline Accounts payable & 6.4% & of net sales: \\ \hline Accrued compensation (current liability) & 7.2% & of net sales \\ \hline Accrued compensation and retirement benefits (noncurrent liability) & & No change \\ \hline Accrued income taxes (current liability) & 1.996 & of net sales \\ \hline Other accrued expenses & 9.6% & of net sales \\ \hline Accrued income taxes (noncurrent liability) & 9.3% & of net sales \\ \hline Deferred tax liabilities & 4.2% & of net sales \\ \hline Other liabilities & 2.5% & of net sales \\ \hline Ordinary shares & & No change: \\ \hline Accumulated other comprehensive loss & & No change \\ \hline Net income attributable to noncontrolling interest & $19 & million \\ \hline Dividends in FY2020 & $2,853 & million \\ \hline CAPEX in FY2019 & $1,134 & smillion, forecast CAPEX at historic is of net sales \\ \hline Depreciation expense in FY2020: & $950 & million \\ \hline Amortization expense in FY2020 & $1,914 & million \\ \hline Debt due in FY2020 & $838 & million \\ \hline Debt due in Frzo21 & $2,058 & million \\ \hline \end{tabular} \begin{tabular}{|l|r|} \hline \multicolumn{1}{|c|}{\begin{tabular}{c} Medtronic PLC \\ Consolidated Balance Sheet \\ \$ millions \end{tabular}} & \\ \hline Current assets & \\ \hline Cash and cash equivalents & $ \\ \hline Investments & 4,393 \\ \hline Accounts receivable, net & 5,455 \\ \hline Inventories, net & 6,222 \\ \hline Other current assets & 3,753 \\ \hline Total current assets & 1,029 \\ \hline Property, plant, and equipment, net & 20,852 \\ \hline Goodwill & 4,675 \\ \hline Other intangible assets, net & 39,959 \\ \hline Tax assets & 20,560 \\ \hline Other assets & 729 \\ \hline Total assets & 1,014 \\ \hline Current liabilities & 87,789 \\ \hline Current debt obligations & $ \\ \hline Accounts payable & 838 \\ \hline Accrued compensation & 1,953 \\ \hline Accrued income taxes & 2,189 \\ 567 \\ \hline \end{tabular} \begin{tabular}{|c|c|} \hline Current debt obligations & 838x \\ \hline Accounts payable & 1,953x \\ \hline Accrued compensation & 2,189x \\ \hline Accrued income taxes & 567x \\ \hline Other accrued expenses & 2,925 \\ \hline Total current liabilities & 8,472 \\ \hline Long-term debt & 24,486 \\ \hline Accrued compensation and retirement benefits & 1,651 \\ \hline Accrued income taxes & 2,838 \\ \hline Deferred tax liabilities & 1,278 \\ \hline Other liabilities & 363 \\ \hline Total liabilities & 39,088 \\ \hline \multicolumn{2}{|l|}{ Shareholders' equity } \\ \hline Ordinary shares & 0 \\ \hline Additional paid-in capital & 25,021 \\ \hline Retained earnings & 26,270 \\ \hline Accumulated other comprehensive loss & (2,711) \\ \hline Total shareholders' equity & 48,580 \\ \hline Noncontrolling interests & 121 \\ \hline Total equity & 48,701 \\ \hline \end{tabular} \begin{tabular}{|c|c|c|c|} \hline Other liabilities & & 363 & x \\ \hline Total liabilities & & 39,088 & x \\ \hline \multicolumn{4}{|l|}{ Shareholders' equity } \\ \hline Ordinary shares & & & \\ \hline Additional paid-in capital & & 25,021 & \\ \hline Retained earnings & & 26,270 & x \\ \hline Accumulated other comprehensive loss & & (2,711) & \\ \hline Total shareholders' equity & & 48,580 & x \\ \hline Noncontrolling interests & & 121 & x \\ \hline Total equity & & 48,701 & x \\ \hline Total liabilities and equity & $ & 87,789 & x \\ \hline \end{tabular}